{{noteTA|G1=生命科学}}
{{expand|time=2015-06-30T12:15:46+00:00}}
[[Image:激动剂效能.png|right]]的效能]]
'''超级激动剂'''（{{lang-en|superagonist}}）在[[药理学|药理学]]中是指一种能作用于[[受体_(生物化学)|受体]]的激动剂，它产生的最大反应比[[内源|内源]][[激动剂|激动剂]]更大。因此超级激动剂的[[内在活性|内在活性]]大于100%。<ref name="pmid12113824">{{Cite journal | author = Carlier PR, Chow ES, Barlow RL, Bloomquist JR | title = Discovery of non-zwitterionic GABA<sub>A</sub> receptor full agonists and a superagonist | journal = Bioorg. Med. Chem. Lett. | volume = 12 | issue = 15 | pages = 1985–8 |date=August 2002 | pmid = 12113824 | doi = 10.1016/S0960-894X(02)00299-8| url =  }}</ref><ref name="pmid12205290">{{Cite journal | author = Tan CM, Wilson MH, MacMillan LB, Kobilka BK, Limbird LE | title = Heterozygous α2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 99 | issue = 19 | pages = 12471–6 |date=September 2002 | pmid = 12205290 | pmc = 129469 | doi = 10.1073/pnas.122368499 | url =  }}</ref>例如{{link-en|戈舍瑞林|goserelin}}就是一种{{link-en|促性腺激素释放激素受体|Gonadotropin-releasing hormone receptor}}的超级激动剂。<ref>http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019726s054,020578s032lbl.pdf {{Wayback|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019726s054,020578s032lbl.pdf |date=20191111125454 }} [[FDA|FDA]]的批准文件</ref>

==参见==
* [[激动剂|激动剂]]

==參考資料==
{{reflist}}

{{药理学}}

[[Category:藥理學|Category:藥理學]]